O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+4.92%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.8B
AUM Growth
+$11.8B
(+3.8%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
154
New
22
Increased
42
Reduced
28
Closed
21
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$267M |
| 2 |
Boston Scientific
BSX
|
$145M |
| 3 |
AbbVie
ABBV
|
$124M |
| 4 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$109M |
| 5 |
Community Health Systems
CYH
|
$96.3M |
Top Sells
| 1 |
Perrigo
PRGO
|
$207M |
| 2 |
Zimmer Biomet
ZBH
|
$111M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$107M |
| 4 |
ACT.PRA
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
|
$105M |
| 5 |
Stryker
SYK
|
$88.6M |
Sector Composition
| 1 | Healthcare | 87.46% |
| 2 | Financials | 0.24% |
| 3 | Technology | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYNA
76
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $23.3M | 0.19% |
+1,140,325
| New | +$23.3M |
|
|
77
Zimmer Biomet
ZBH
$20.7B
| $23.2M | 0.19% |
212,300
-1,015,700
| -83% | -$111M |
|
78
Xencor
XNCR
$591M
| $23M | 0.19% |
1,044,615
| – | – |
|
|
MRTX
79
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.4M | 0.18% |
680,500
-586,500
| -46% | -$18.5M |
|
80
Jazz Pharmaceuticals
JAZZ
$7.94B
| $20.2M | 0.17% |
115,000
| – | – |
|
|
PVLA
81
Palvella Therapeutics, Inc. Common Stock
PVLA
$578M
| $20M | 0.17% |
+7,259,620
| New | +$20M |
|
|
CNXR
82
DELISTED
Connecture, Inc.
CNXR
| $18.4M | 0.15% |
1,740,000
| – | – |
|
83
Teva Pharmaceuticals
TEVA
$21.5B
| $18.1M | 0.15% |
307,000
-784,000
| -72% | -$46.3M |
|
|
84
Stryker
SYK
$147B
| $17.8M | 0.15% |
186,000
-927,000
| -83% | -$88.6M |
|
85
eHealth
EHTH
$123M
| $16.5M | 0.14% |
1,300,000
+1,026,900
| +376% | +$13M |
|
|
MRGE
86
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $15.9M | 0.13% |
3,308,400
-1,320,100
| -29% | -$6.34M |
|
|
ADXS
87
DELISTED
Advaxis, Inc.
ADXS
| $15.4M | 0.13% |
755,100
+325,000
| +76% | +$6.61M |
|
|
IMGN
88
DELISTED
Immunogen Inc
IMGN
| $14.8M | 0.12% |
+1,030,000
| New | +$14.8M |
|
89
Vertex Pharmaceuticals
VRTX
$101B
| $14.2M | 0.12% |
115,000
-20,000
| -15% | -$2.47M |
|
90
Insulet
PODD
$24B
| $14M | 0.12% |
453,000
-1,544,000
| -77% | -$47.8M |
|
|
SVA
91
DELISTED
Sinovac Biotech, Ltd
SVA
| $14M | 0.12% |
2,667,500
| – | – |
|
92
The Ensign Group
ENSG
$9.89B
| $12.6M | 0.11% |
+247,600
| New | +$12.6M |
|
|
CLLS
93
Cellectis
CLLS
$263M
| $12.6M | 0.11% |
350,000
+50,000
| +17% | +$1.8M |
|
|
AET
94
DELISTED
Aetna Inc
AET
| $12.2M | 0.1% |
96,000
+2,000
| +2% | +$255K |
|
95
Cardinal Health
CAH
$35.8B
| $12.2M | 0.1% |
146,000
-814,000
| -85% | -$68.1M |
|
96
MacroGenics
MGNX
$118M
| $12M | 0.1% |
+317,000
| New | +$12M |
|
|
SAGE
97
DELISTED
Sage Therapeutics
SAGE
| $11M | 0.09% |
150,000
-262,335
| -64% | -$19.2M |
|
98
Abbott
ABT
$228B
| $10.4M | 0.09% |
211,000
| – | – |
|
99
Seres Therapeutics
MCRB
$167M
| $10.2M | 0.09% |
+246,645
| New | +$10.2M |
|
|
ONCE
100
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $10M | 0.08% |
166,500
+39,500
| +31% | +$2.38M |
|